Vera Therapeutics Inc (VERA)
49.00
-0.43
(-0.87%)
USD |
NASDAQ |
Nov 14, 16:00
49.99
+0.99
(+2.02%)
Pre-Market: 09:28
Vera Therapeutics Enterprise Value: 2.800B for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 2.800B |
| November 13, 2024 | 2.827B |
| November 12, 2024 | 2.771B |
| November 11, 2024 | 2.779B |
| November 08, 2024 | 2.742B |
| November 07, 2024 | 2.803B |
| November 06, 2024 | 2.733B |
| November 05, 2024 | 2.718B |
| November 04, 2024 | 2.496B |
| November 01, 2024 | 2.413B |
| October 31, 2024 | 2.200B |
| October 30, 2024 | 1.933B |
| October 29, 2024 | 2.062B |
| October 28, 2024 | 2.302B |
| October 25, 2024 | 1.958B |
| October 24, 2024 | 1.887B |
| October 23, 2024 | 1.892B |
| October 22, 2024 | 1.937B |
| October 21, 2024 | 1.947B |
| October 18, 2024 | 1.962B |
| October 17, 2024 | 1.892B |
| October 16, 2024 | 1.898B |
| October 15, 2024 | 1.910B |
| October 14, 2024 | 2.018B |
| October 11, 2024 | 2.048B |
| Date | Value |
|---|---|
| October 10, 2024 | 1.909B |
| October 09, 2024 | 1.839B |
| October 08, 2024 | 1.823B |
| October 07, 2024 | 1.899B |
| October 04, 2024 | 1.944B |
| October 03, 2024 | 1.925B |
| October 02, 2024 | 1.995B |
| October 01, 2024 | 2.054B |
| September 30, 2024 | 2.129B |
| September 27, 2024 | 2.048B |
| September 26, 2024 | 2.169B |
| September 25, 2024 | 2.129B |
| September 24, 2024 | 2.227B |
| September 23, 2024 | 2.109B |
| September 20, 2024 | 2.011B |
| September 19, 2024 | 1.968B |
| September 18, 2024 | 1.877B |
| September 17, 2024 | 1.860B |
| September 16, 2024 | 1.864B |
| September 13, 2024 | 1.722B |
| September 12, 2024 | 1.621B |
| September 11, 2024 | 1.726B |
| September 10, 2024 | 1.725B |
| September 09, 2024 | 1.765B |
| September 06, 2024 | 1.705B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
60.56M
Minimum
Jan 09 2023
2.827B
Maximum
Nov 13 2024
730.76M
Average
432.92M
Median
Sep 26 2022
Enterprise Value Benchmarks
| PROCEPT BioRobotics Corp | 4.503B |
| NovaBay Pharmaceuticals Inc | 2.833M |
| Palatin Technologies Inc | 11.39M |
| iBio Inc | 5.346M |
| Theriva Biologics Inc | -13.34M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -46.63M |
| Total Expenses (Quarterly) | 49.80M |
| EPS Diluted (Quarterly) | -0.85 |
| Earnings Yield | -5.33% |